Showing results (11-20 of 101) with videos related to
Sort By:
Pageof 11
Current Opinion in Investigational Drugs (London, England : 2000)|September 26, 2003
Pharmacokinetics and pharmacodynamics in the development of antifungal compoundsDavid AndesInfectious Disease Clinics of North America|January 9, 2004
Clinical pharmacodynamics of antifungalsDavid AndesInfectious Disease Clinics of North America|September 21, 2006
Pharmacokinetics and pharmacodynamics of antifungalsDavid AndesCurrent Opinion in Infectious Diseases|January 11, 2005
Clinical utility of antifungal pharmacokinetics and pharmacodynamicsDavid AndesCritical Care Clinics|December 15, 2010
Fungal sepsis: optimizing antifungal therapy in the critical care settingAlexander Lepak, David AndesExpert Opinion on Drug Metabolism & Toxicology|August 19, 2007
CNS pharmacokinetics of antifungal agentsShravan Kethireddy, David AndesFungal Genetics and Biology : FG & B|September 10, 2013
Insights into fungal pathogenesis from the iatrogenic epidemic of Exserohilum rostratum fungal meningitisDavid Andes, Arturo CasadevallCurrent Topics in Microbiology and Immunology|January 1, 2022
Contributions of Extracellular Vesicles to Fungal Biofilm PathogenesisMarienela Heredia, David AndesTherapeutic Drug Monitoring|March 28, 2008
Therapeutic drug monitoring of antifungals: pharmacokinetic and pharmacodynamic considerationsJeannina Smith, David AndesAntimicrobial Agents and Chemotherapy|February 20, 2007
In vivo pharmacodynamic activity of the glycopeptide dalbavancinDavid Andes, William A CraigPageof 11